HALO•benzinga•
HC Wainwright & Co. Maintains Buy on Halozyme Therapeutics, Raises Price Target to $70
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga